GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GE Healthcare Technologies GEHC · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500Nasdaq-100

Compare

84.03

+2.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

29 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 8Strong buy
  • 13Buy
  • 8Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 84.03Average target 78.73

Low
65.00
Average
78.73
Median
80.00
High
90.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$21.85bn$22.92bn$24.07bn$25.42bn$26.88bn
Revenue, highest$21.96bn$23.05bn$24.69bn$25.67bn$27.14bn
Revenue, lowest$21.69bn$22.66bn$23.69bn$25.19bn$26.63bn
Earnings per share5.005.506.116.797.53
Earnings per share, highest5.075.626.616.887.62
Earnings per share, lowest4.955.205.456.717.44
Analysts1315161414

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast1.201.041.041.431.070.940.931.29
Reported1.341.130.991.441.071.061.011.45
Difference+11.7%+8.7%-4.8%+1.0%-0.2%+13.2%+8.4%+12.5%

Rating changes

Latest broker notes

  • UBSNeutral
  • Wells FargoOverweight
  • Evercore ISI GroupOutperform
  • CitigroupNeutral
  • BTIGBuy
  • UBSNeutral
  • UBSSell → Neutral
  • Wells FargoOverweight
  • JP MorganNeutral
  • Goldman SachsBuy → Neutral
  • Evercore ISI GroupOutperform
  • CitigroupNeutral

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 20.1%.

Model fair value

83.09

From earnings 83.09, from revenue 83.94.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.